|
Lankester AC, Neven B, Mahlaoui N, von Asmuth EGJ, Courteille V, Alligon M, Albert MH, Serra IB, Bader P, Balashov D, Beier R, Bertrand Y, Blanche S, Bordon V, Bredius RG, Cant A, Cavazzana M, Diaz-de-Heredia C, Dogu F, Ehlert K, Entz-Werle N, Fasth A, Ferrua F, Ferster A, Formankova R, Friedrich W, Gonzalez-Vicent M, Gozdzik J, Gungor T, Hoenig M, Ikinciogullari A, Kalwak K, Kansoy S, Kupesiz A, Lanfranchi A, Lindemans CA, Meisel R, Michel G, Miranda NAA, Moraleda J, Moshous D, Pichler H, Rao K, Sedlacek P, Slatter M, Soncini E, Speckmann C, Sundin M, Toren A, Vettenranta K, Worth A, Yesilipek MA, Zecca M, Porta F, Schulz A, Veys P, Fischer A, Gennery AR. Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort. J Allergy Clin Immunol. 2022 May;149(5):1744-1754.e8. doi: 10.1016/j.jaci.2021.10.017. Epub 2021 Oct 27. PubMed PMID: 34718043.
AÑO: 2022; IF: 14.2
|
34718043
|
Lopez-Guillermo A, Canales MA, Dlouhy I, Mercadal S, Briones J, Martin Garcia-Sancho A, Sancho JM, Moraleda JM, Terol MJ, Salar A, Palomera L, Gardella S, Jarque I, Ferrer S, Bargay J, Lopez A, Panizo C, Muntanola A, Montalban C, Conde E, Hernandez MT, Soler A, Garcia Marco JA, Deben G, Marin J, Tomas JF; PETHEMA/GELTAMO/GELCAB Spanish Intergroup. A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results. Leuk Lymphoma. 2022 Jan;63(1):93-100. doi: 10.1080/10428194.2021.1971216. Epub 2021 Aug 30. PubMed PMID: 34459702.
AÑO: 2022; IF: 2.6
|
|
Garcia-Bernal D, Blanquer M, Martinez CM, Garcia-Guillen AI, Garcia-Hernandez AM, Carmen Alguero M, Yanez R, Lamana ML, Moraleda JM, Sackstein R. Enforced mesenchymal stem cell tissue colonization counteracts immunopathology. NPJ Regen Med. 2022 Oct 19;7(1):61. doi: 10.1038/s41536-022-00258-z. PubMed PMID: 36261464; PubMed Central PMCID: PMC9582223.
AÑO: 2022; IF: 14.404
|
|
Molina ML, Garcia-Bernal D, Salinas MD, Rubio G, Aparicio P, Moraleda JM, Martinez S, Valdor R. Chaperone-Mediated Autophagy Ablation in Pericytes Reveals New Glioblastoma Prognostic Markers and Efficient Treatment Against Tumor Progression. Front Cell Dev Biol. 2022 Mar 18;10:797945. doi: 10.3389/fcell.2022.797945. eCollection 2022. PubMed PMID: 35419364; PubMed Central PMCID: PMC8997287.
AÑO: 2022; IF: 5.5
|
|
Bueno C, Blanquer M, Garcia-Bernal D, Martinez S, Moraleda JM. Binucleated human bone marrow-derived mesenchymal cells can be formed during neural-like differentiation with independence of any cell fusion events. Sci Rep. 2022 Nov 30;12(1):20615. doi: 10.1038/s41598-022-24996-8. PubMed PMID: 36450873; PubMed Central PMCID: PMC9712539.
AÑO: 2022; IF: 4.6
|